市場調査レポート

商品コード

1754098

バイオマテリアル市場レポート：タイプ別、用途別、地域別、2025年～2033年

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2025-2033

出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 437,254円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 583,054円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 728,854円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.80円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオマテリアル市場規模は2024年に1,261億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに2,897億米ドルに達し、2025年から2033年にかけて9.7%の成長率（CAGR）を示すと予測しています。ヘルスケア産業における継続的な進歩が、心血管疾患の有病率の上昇とともに、主に市場を牽引しています。

バイオマテリアル市場分析：

主な市場促進要因：筋骨格系疾患の患者数の増加が市場促進要因の1つとなっています。さらに、創傷閉鎖のための溶解可能な縫合糸やドレッシング材、ステープル、クリップへのこれらの材料の採用が増加していることも、もう一つの重要な成長促進要因として作用しています。
主要市場動向：ポリマー合成、タンパク質・ペプチド工学、分子自己組織化、微細加工技術におけるいくつかの進歩は、市場を強化する新たな動向のひとつです。
地理的動向：北米は、しばしば医療介入を必要とする老年人口の拡大により、市場全体で明確な優位性を示しています。さらに、研究機関の増加や強固なヘルスケアインフラが、この地域の市場成長を後押ししています。
競合情勢：バイオマテリアル市場概要によると、著名な企業にはBASF SE、Berkeley Advancedバイオマテリアル、Carpenter Technology Corporation、Collagen Matrix Inc.、CoorsTek Inc.、Corbion N.V.、Dentsply Sirona、Evonik Industries AG、Johnson &Johnson、Koninklijke DSM N.V.、Medtronic plc、Stryker Corporation、Victrex plc、Zimmer Biometなどがあります。
課題と機会：厳しい規制の枠組みと広範な前臨床試験が市場の足かせとなっています。しかし、臨床使用前に生体適合性を評価するためのより予測的な生体内および生体外のモデルの導入は、予測期間中に市場を拡大すると予想されます。

バイオマテリアル市場動向：

3Dプリンティング技術の開発

3Dプリンティング技術をはじめとする斬新なイノベーションの導入により、医療用インプラントやデバイスの設計・製造方法が改善されつつあります。さらに、従来の方法では困難または不可能であった、患者固有の複雑な形状の製造も可能になっています。その結果、これらの技術は、歯科、整形外科、補綴など、解剖学的精度が重要な分野で幅広く応用されています。これが、有利なバイオマテリアル市場の最近のビジネスチャンスの一つとなっています。例えば、2024年2月、Nanavati Max Super Specialty Hospitalはムンバイに医療用3Dプリンティングラボを開設し、高精度の手術を容易にしました。この先駆的な施設は腫瘍学と密接に統合されており、再建整形外科、腫瘍学、特殊歯科手術において正確かつ慎重に行うことが求められる最先端の精密手術を提供しています。さらに、バイオマテリアルでは、個々の患者の解剖学的構造に合わせたカスタマイズされた複雑な医療機器やインプラントを作成するための3Dプリンティング技術が広く統合され、世界中でさらに幅広い支持を集めています。例えば、2023年10月には、ベルゲンのハウケラン大学病院の作業療法士が、3Dプリンティングとスキャニング技術を使用して、痛みの軽減、劣化の最小化、患者のコンプライアンスの向上などを実現する、パーソナライズされた手の装具の開発を支援する研究が発表されました。これとは別に、3Dプリンティングでは、機械的特性の異なる材料の勾配を組み込むことができ、これも市場にプラスの影響を与えています。例えば、2023年10月、エボニックは多数の医療用途向けにインプラントグレードのフィラメントと炭素繊維強化PEEKを発売しました。さらに、これらの技術は慢性疾患の治療を支援するものであり、今後数年間のバイオマテリアル市場全体の見通しを後押しすると予測されています。例えば、2023年7月には、韓国バイオサイエンス・バイオテクノロジー研究院（Korea Research Institute of Bioscience and Biotechnology）、韓国機械材料研究院（Korea Institute of Machinery and Materials）、科学情報通信部（Ministry of Science and ICT）管轄の研究所との共同研究により、ナチュラルキラー（NK）免疫細胞の機能を強化する世界初の3Dバイオプリンティング技術が発表されました。

組織工学の革新

組織工学は研究において重要な役割を果たしています。組織機能を維持、回復、改善するための生物学的代替物の開発において、絶大な人気を博しています。例えば、オルガナバイオ社は2023年6月、再生医療と細胞治療の進歩を加速するために特別に設計されたNeoPAC胎盤と臍帯組織の導入を発表しました。さらにオルガナバイオは、研究用（RUO）と臨床グレードの組織の両方を提供することで、研究者に出生組織の潜在能力を引き出すことを奨励し、それによって多くの病状に対処する革新的な治療法の開発を可能にします。これとは別に、新組織の形成を促進するために望ましい細胞間相互作用を引き起こすように設計された材料である新規足場に対する需要の高まりも市場を上昇させています。例えば、2023年6月、組織工学の主要なイノベーターの1つである3DBioFibR社は、2つの新しいコラーゲン繊維製品、すなわちCollaFibR 3DとμCollaFibR足場をリリースしました。これらの製品は、組織培養や組織工学の用途に大きな利点をもたらします。さらに、より構造的・機能的に正確な組織工学を可能にするために、さまざまな組織による研究開発活動や研究施設への投資の高まりが、調査キーワード市場の収益に貢献しています。例えば、2023年1月、National Institute of Biomedical Imaging and Bioengineering（NIBIB）は、最先端技術の検証、開発、普及を加速するための新しい学内研究プログラムであるCenter for Biomedical Engineering Technology Acceleration（BETAセンター）を設立しました。同センターは、バイオセンシング、人工・合成生物学、バイオメディカルイメージング、ナノ材料、バイオマテリアルなど、いくつかの分野に焦点を当てています。

創傷ドレッシングにおける用途の拡大

バイオマテリアルは、急性および慢性の傷害を含む多くのタイプの傷の治癒プロセスや治療結果の改善に役立つため、高度創傷ドレッシングへの採用が増加しており、重要な成長促進要因として作用しています。このほか、主要企業は持続可能な創傷治療用材料を開発しています。例えば2024年3月、科学技術省傘下の科学技術高等研究所（IASST）の科学者チームが、バナナ繊維を使った環境に優しい創傷ドレッシングを発表しました。さらに、この革新的なドレッシング材の製造に使用される材料はすべて地元で入手可能な天然材料であるため、製造工程は費用対効果が高く、シンプルで無害です。これとは別に、バイオ材料をベースとした創傷ドレッシングへの傾斜の高まりが、バイオマテリアル市場価格を押し上げています。創傷ドレッシングは、発泡体、ハイドロゲル、フィルムなど様々な材料から製造され、抗菌剤のような生物活性物質が含まれていることが多く、感染症を減らし、組織の再生を促進します。例えば、2022年5月、スウェーデンの医療機器新興企業であるAmferia ABは、両親媒性抗菌ハイドロゲルに基づく抗菌材料について、米国特許商標庁（USPTO）から基礎特許を付与されました。これに伴い、2023年6月、Journal of Biomaterials Advancesに掲載された調査結果によると、BelfastのQueen's Universityの研究チームは、足場とも呼ばれる3Dプリント包帯を設計し、糖尿病性足潰瘍（DFU）を治癒する画期的な治療方法を提示しました。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第9章 SWOT分析

概要
強み
弱み
機会
脅威

第10章バリューチェーン分析

第11章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第12章価格分析

第13章競合情勢

市場構造
主要企業
主要企業のプロファイル
- BASF SE
- Berkeley Advanced Biomaterials
- Carpenter Technology Corporation
- Collagen Matrix Inc.
- CoorsTek Inc.
- Corbion N.V.
- Dentsply Sirona
- Evonik Industries AG
- Johnson & Johnson
- Koninklijke DSM N.V.
- Medtronic plc
- Stryker Corporation
- Victrex plc
- Zimmer Biomet

図表

List of Figures

Figure 1: Global: Biomaterials Market: Major Drivers and Challenges
Figure 2: Global: Biomaterials Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biomaterials Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Biomaterials Market: Breakup by Type (in %), 2024
Figure 5: Global: Biomaterials Market: Breakup by Application (in %), 2024
Figure 6: Global: Biomaterials Market: Breakup by Region (in %), 2024
Figure 7: Global: Biomaterials (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Biomaterials (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Biomaterials (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Biomaterials (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Biomaterials (Ceramic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Biomaterials (Ceramic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Biomaterials (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Biomaterials (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Biomaterials (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Biomaterials (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Biomaterials (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Biomaterials (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Biomaterials (Orthopedics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Biomaterials (Orthopedics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Biomaterials (Wound Care) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Biomaterials (Wound Care) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Biomaterials (Dental) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Biomaterials (Dental) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Biomaterials (Plastic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Biomaterials (Plastic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Biomaterials (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Biomaterials (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: North America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: North America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: United States: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: United States: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Canada: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Canada: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Asia-Pacific: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Asia-Pacific: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: China: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: China: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Japan: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Japan: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: India: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: India: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: South Korea: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: South Korea: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Australia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Australia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Indonesia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Indonesia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Europe: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Europe: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Germany: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Germany: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: France: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: France: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: United Kingdom: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: United Kingdom: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Italy: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Italy: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Spain: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Spain: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Russia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Russia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Latin America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Latin America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Brazil: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Brazil: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Mexico: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Mexico: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Middle East and Africa: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Middle East and Africa: Biomaterials Market: Breakup by Country (in %), 2024
Figure 77: Middle East and Africa: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Global: Biomaterials Industry: SWOT Analysis
Figure 79: Global: Biomaterials Industry: Value Chain Analysis
Figure 80: Global: Biomaterials Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biomaterials Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Biomaterials Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Biomaterials Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Biomaterials Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Biomaterials Market: Competitive Structure
Table 6: Global: Biomaterials Market: Key Players

Product Code: SR112025A5892

The global biomaterials market size reached USD 126.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 289.7 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.
Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.
Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.
Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.
Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

Breakup by Type:

Natural Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

Neurology
Cardiology
Orthopedics
Wound Care
Dental
Plastic Surgery
Others

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

BASF SE
Berkeley Advanced Biomaterials
Carpenter Technology Corporation
Collagen Matrix Inc.
CoorsTek Inc.
Corbion N.V.
Dentsply Sirona
Evonik Industries AG
Johnson & Johnson
Koninklijke DSM N.V.
Medtronic plc
Stryker Corporation
Victrex plc
Zimmer Biomet

Key Questions Answered in This Report

1.What was the size of the global biomaterials market in 2024?
2.What is the expected growth rate of the global biomaterials market during 2025-2033?
3.What are the key factors driving the global biomaterials market?
4.What has been the impact of COVID-19 on the global biomaterials market?
5.What is the breakup of the global biomaterials market based on type?
6.What are the key regions in the global biomaterials market?
7.Who are the key players/companies in the global biomaterials market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Biomaterials Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Natural Biomaterial
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Metallic Biomaterial
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Ceramic Biomaterial
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Polymeric Biomaterial
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Application

7.1 Neurology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Cardiology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Orthopedics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Wound Care
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Dental
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Plastic Surgery
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 BASF SE
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Berkeley Advanced Biomaterials
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Carpenter Technology Corporation
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Collagen Matrix Inc.
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
- 13.3.5 CoorsTek Inc.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
- 13.3.6 Corbion N.V.
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
- 13.3.7 Dentsply Sirona
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Evonik Industries AG
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Johnson & Johnson
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Koninklijke DSM N.V.
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis
- 13.3.11 Medtronic plc
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
  - 13.3.11.3 Financials
  - 13.3.11.4 SWOT Analysis
- 13.3.12 Stryker Corporation
  - 13.3.12.1 Company Overview
  - 13.3.12.2 Product Portfolio
  - 13.3.12.3 Financials
  - 13.3.12.4 SWOT Analysis
- 13.3.13 Victrex plc
  - 13.3.13.1 Company Overview
  - 13.3.13.2 Product Portfolio
  - 13.3.13.3 Financials
- 13.3.14 Zimmer Biomet
  - 13.3.14.1 Company Overview
  - 13.3.14.2 Product Portfolio
  - 13.3.14.3 Financials
  - 13.3.14.4 SWOT Analysis

バイオマテリアル市場レポート：タイプ別、用途別、地域別、2025年～2033年

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2025-2033

バイオマテリアル市場分析：

バイオマテリアル市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のバイオマテリアル市場

第6章 市場内訳：タイプ別

第7章 市場内訳：用途別

第8章 市場内訳：地域別

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

第12章 価格分析

第13章 競合情勢